Therefore, the transient depletion of Treg, the blocking of IL-10 and TGF-β, the fine control of NKT-derived IFN-γ in the tumor microenvironment may enhance therapeutic HPV vaccine potency. The gene discussed is IFNG; the disease is neoplasm.